期刊文献+

鲍曼不动杆菌对β-内酰胺类药物耐药机制的研究 被引量:5

Study on mechanism of resistance of Acinetobacter bauannii to β-Lactams
下载PDF
导出
摘要 目的调查耐药鲍曼不动杆菌β-内酰胺酶基因型流行情况,为医院合理使用抗菌药物提供参考依据。方法用聚合酶链反应(PCR)方法对7株鲍曼不动杆菌的8种相关β-内酰胺酶基因型(TEM、AmpC、VIM、IMP、PER、GES、VEB、SHV)进行检测,并通过琼脂凝胶电泳后进行成像验证。结果 7株鲍曼不动杆菌中blaTEM染色体检测阳性有7株、质粒阳性7株;blaAmpC染色体阳性3株、质粒阳性6株;blaPER染色体阳性4株;其余β-内酰胺酶基因未检出,其中有1株同时携带有3种耐药基因型。结论β-内酰胺类药物耐药基因以TEM型最为常见,其次为ampC型、PER型,其余型未见发现;同一株耐药菌可携带多种耐药基因。 Objective To study the prevalence of genotypes of muhidrug resistance of Acinetobacter baumannii in this hospital and to pro- vide reference to rational use of antibacterials. Methods Among 7 strains of A. baumannii, 8 kinds of β laetam - resistant genotypes ( TEM, AmpC, VIM, IMP, PER, GES, VEB and SHV) were detected by polymerase chain reaction (PCR) assay, and they were verified by agarose gel electrophoresis. Results In these 7 strains, blaTEM was positive in chromosome and plasmid of 7 strains, blaAmpC was positive in chromosome of 3 strains and plasmid of 6 strains, blaPER was positive in chromosome of 4 strains, and others were negative. There was one strain carrying three genotypes. Conclusion In this hospital, blaTEM was the most important resistant genotype, and blaAmpC, and blaPER were the next, and no other types had been found. A β lactam - resistant strain can carry more than one resistant genotype.
出处 《临床和实验医学杂志》 2013年第1期20-21,23,共3页 Journal of Clinical and Experimental Medicine
基金 连云港市卫生局课题 课题编号09051
关键词 鲍曼不动杆菌 Β-内酰胺类药物 耐药机制 聚合酶链反应 Acinetobacter baumannii β -lactams Resistance mechanism Polymerase chain reaction
  • 相关文献

参考文献8

二级参考文献41

  • 1王辉,刘颖梅,陈民钧,孙宏莉,谢秀丽,徐英春.鲍曼不动杆菌对碳青霉烯类耐药机制的研究[J].中国医学科学院学报,2003,25(5):567-572. 被引量:44
  • 2周月清,陆开来,糜祖煌.鲍曼不动杆菌TEM基因及氨基糖苷类修饰酶基因初步研究[J].中华检验医学杂志,2005,28(2):200-202. 被引量:64
  • 3钱小毛,赵仲农,王亚玲.绍兴地区铜绿假单胞菌亚胺培南耐药机制研究[J].中华医院感染学杂志,2005,15(7):815-818. 被引量:36
  • 4Afcal-shah M, Lirermore DM. Worldwide emergency of carbapenem-resistant Acinetobacter spp.J Antimicrob Chemother, 1998,41:576-577.
  • 5Dalla-costa LM, Coelho JM, Souza HA, et al .Outbreak of carbapenem-resistant Acinetobacter baumannii producing the OXA-23 enzyme in Curitiba,Brazil J Clin Microbiol ,2003,41:3403-3406.
  • 6Lepez-Otsoa F, Gallego L, Towner KJ,et al.Endemic carbapenem resistance associated with OXA-40 carbapenemase among Acinetobacter baumannii isolated from a hospital in northern Spain.J Clin Microbiol, 2002,40:4741-4743.
  • 7Zarrilli R, Crispino M, Bagattini M,et al.Molecular epidemiology of sequential outbreak of Acinetobacter baumannii in an ICU shows the emergence of carbapenem resistance.J Clin Microbiol ,2004,42:946-953.
  • 8Koeleman JG, Stoof J, van der Bijl, et al. Identification of epidemic strains of Acinetobacter baumannii by integrase gene PCR. J Clin Microbiol ,2001,39:8-13.
  • 9史伟峰 姜建平 徐宁.鲍曼不动杆菌多药外排作用与耐药性的关系[A]..全国检验医学感染控制和病原监测学术研讨会论文集[C].,2004.139-141.
  • 10Limansky AS,Mussi MA, Viale AM . Loss of 29 kD outer membrane protein in Acenetobacter baumanii is associated with Imipenem resistance. J Clin Microbiol ,2002,40:4776-4778.

共引文献326

同被引文献48

  • 1叶应抚,王毓三,申子瑜.全国临床检验操作规程[M].第3版.南京:东南大学出版社,2006:736-754.
  • 2Yong D, Toleman MA, Giske CG, et al. Characterization ot anew metallo-β-lactamase gene,blaNDM-1, and a novel erythro- mycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India[ J]. An- timicrob Agents Chemother, 2009, 53 (12):5046-5054.
  • 3Rogues AM, Dumartin C, Amadeo B, et al. Relationship between rates of antimicrobial consumption and the incidence of antimicrobial resistance In Staphylococcus aureus and Pseudomonas aeruginosa isolates from 47 French hospitals [J]. Infect Control Hosp Epidemiol, 2007, 28 (12) :1389- 1395.
  • 4Fernandez-cuenca f,martinez-marfinez L,conelo mc,et al,relarionship betweenbeta-lactamase production,outet membraneprotein and penicillin-binding profiles on theactivity of carbapenems against clinical isolates of acinetobacter baumannii[J].j antimictibchemother,2003,5(3);565-547.
  • 5Freire A T, Melnyk V, Kim M J, et al. Comparison of tigecycline with imipenem/cilastatin for the treatment of hospital-acquired pneumonia [J]. Diagn Microbiol Infect Dis, 2010, 68(2): 140-151.
  • 6Orsini J A, Moate P J, Boston R C, et al. Pharmacokinetics of imipenem-cilastafin following intravenous administration in healthy adult horses [J]. J Vet Pharmacol Ther, 2005, 28(4): 355-361.
  • 7高春明.39株鲍曼不动杆菌耐药性分析与aac-6-Ib基因检测.
  • 8Potron A, Munoz-Price LS, Nordmann P, Cleary T, Poirel L. Cenetic features of CTX-M-15-producing Acinetobacter baumannii from Haiti. hntimicrob Agents Chemother. 2011 55(12): 5946-8.
  • 9Bonnin llh, Nordmann P, Poirel L. Screening and deciphering antibiotic resistance in hcinetobacter baumannii: a state of the art. Expert Rev Anti Infect Ther. 2013. 11(6): 571-83.
  • 10Chen Y, Zhou Z, Jiang Y, Yu Y. Emergence of NDM-1- producing Acinetobacter baumannii in China. J Antimicrob Chemother. 2011. 66(6): 1255-9.

引证文献5

二级引证文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部